Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Krishnan

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Bioinformation|May 16, 2022
Molecular docking analysis of glycogen phosphorylase with inhibitors from <i>Cissampelos pareira</i> LinnKirubhanand Chandrashekar, Ponnulakshmi Rajagopal, Shazia Fathima Jh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
The New England Journal of Medicine|June 25, 2015
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseKenneth Rosenfield, Michael R Jaff, Christopher J White, et al.
Journal of the American College of Cardiology|January 25, 2023
Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery DiseaseSerdar Farhan, Florian K Enzmann, Patrick Bjorkman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Vascular|December 4, 2018
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysisWilman Olmedo, Pedro A Villablanca, Cristina Sanina, et al.
Heart (British Cardiac Society)|August 4, 2025
Predictors of postprocedural troponin increase in patients undergoing elective percutaneous coronary interventionSean Gilhooley, Mauro Gitto, Alessandro Spirito, et al.
Heart (British Cardiac Society)|March 21, 2025
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Samantha Sartori, Birgit Vogel, et al.
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Bioinformation|May 16, 2022
Molecular docking analysis of glycogen phosphorylase with inhibitors from <i>Cissampelos pareira</i> LinnKirubhanand Chandrashekar, Ponnulakshmi Rajagopal, Shazia Fathima Jh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
The New England Journal of Medicine|June 25, 2015
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseKenneth Rosenfield, Michael R Jaff, Christopher J White, et al.
Journal of the American College of Cardiology|January 25, 2023
Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery DiseaseSerdar Farhan, Florian K Enzmann, Patrick Bjorkman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Vascular|December 4, 2018
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysisWilman Olmedo, Pedro A Villablanca, Cristina Sanina, et al.
Heart (British Cardiac Society)|August 4, 2025
Predictors of postprocedural troponin increase in patients undergoing elective percutaneous coronary interventionSean Gilhooley, Mauro Gitto, Alessandro Spirito, et al.
Heart (British Cardiac Society)|March 21, 2025
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Samantha Sartori, Birgit Vogel, et al.
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Pageof 18